In Reply In response to our study on the implications of removing race from eGFR,1 Ms van der Burgh and colleagues describe advantages of eGFRcys, including potentially improved prediction of cardiovascular events and mortality in patients with CKD.
No takes yet. Share an insight, caveat, or question.
Diao et al. (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: